• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁螯合剂去铁酮可挽救记忆损伤模型中的记忆缺陷、海马脑源性神经营养因子水平和抗氧化防御能力。

Iron chelator deferiprone rescues memory deficits, hippocampal BDNF levels and antioxidant defenses in an experimental model of memory impairment.

机构信息

Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, 90619-900, Brazil.

Laboratory of Genomics and Molecular Biology, Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, 90619-900, Brazil.

出版信息

Biometals. 2018 Dec;31(6):927-940. doi: 10.1007/s10534-018-0135-1. Epub 2018 Aug 16.

DOI:10.1007/s10534-018-0135-1
PMID:30117045
Abstract

Brain-derived neurotrophic factor (BDNF) plays a key role in neural development and physiology, as well as in pathological states. Post-mortem studies demonstrate that BDNF is reduced in the brains of patients affected by neurodegenerative diseases. Iron accumulation has also been associated to the pathogenesis of neurodegenerative diseases. In rats, iron overload induces persistent memory deficits, increases oxidative stress and apoptotic markers, and decreases the expression of the synaptic marker, synaptophysin. Deferiprone (DFP) is an oral iron chelator used for the treatment of systemic iron overload disorders, and has recently been tested for Parkinson's disease. Here, we investigated the effects of iron overload on BDNF levels and on mRNA expression of genes encoding TrkB, p75, catalase (CAT) and NQO1. We also aimed at investigating the effects of DFP on iron-induced impairments. Rats received iron or vehicle at postnatal days 12-14 and when adults, received chronic DFP or water (vehicle). Recognition memory was tested 19 days after the beginning of chelation therapy. BDNF measurements and expression analyses in the hippocampus were performed 24 h after the last day of DFP treatment. DFP restored memory and increased hippocampal BDNF levels, ameliorating iron-induced effects. Iron overload in the neonatal period reduced, while treatment with DFP was able to rescue, the expression of antioxidant enzymes CAT and NQO1.

摘要

脑源性神经营养因子(BDNF)在神经发育和生理学以及病理状态中起着关键作用。尸检研究表明,BDNF 在受神经退行性疾病影响的患者的大脑中减少。铁积累也与神经退行性疾病的发病机制有关。在大鼠中,铁过载会导致持续的记忆缺陷,增加氧化应激和凋亡标志物,并降低突触标志物突触小体素的表达。地拉罗司(DFP)是一种口服铁螯合剂,用于治疗全身性铁过载疾病,最近已用于帕金森病的测试。在这里,我们研究了铁过载对 BDNF 水平以及编码 TrkB、p75、过氧化氢酶 (CAT) 和 NQO1 的基因的 mRNA 表达的影响。我们还旨在研究 DFP 对铁诱导损伤的影响。大鼠在出生后第 12-14 天接受铁或载体,并在成年时接受慢性 DFP 或水(载体)。在螯合治疗开始后 19 天测试识别记忆。在 DFP 治疗的最后一天 24 小时后,在海马体中进行 BDNF 测量和基因表达分析。DFP 恢复了记忆并增加了海马体中的 BDNF 水平,改善了铁诱导的影响。在新生儿期铁过载减少,而 DFP 治疗能够挽救抗氧化酶 CAT 和 NQO1 的表达。

相似文献

1
Iron chelator deferiprone rescues memory deficits, hippocampal BDNF levels and antioxidant defenses in an experimental model of memory impairment.铁螯合剂去铁酮可挽救记忆损伤模型中的记忆缺陷、海马脑源性神经营养因子水平和抗氧化防御能力。
Biometals. 2018 Dec;31(6):927-940. doi: 10.1007/s10534-018-0135-1. Epub 2018 Aug 16.
2
A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload.铁螯合剂与抗氧化剂联合使用可有效减少慢性铁过载大鼠的树突损失、tau蛋白过度磷酸化、β-淀粉样蛋白积累及脑线粒体动力学破坏。
Neuroscience. 2016 Sep 22;332:191-202. doi: 10.1016/j.neuroscience.2016.07.003. Epub 2016 Jul 9.
3
The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.口服铁螯合剂地拉罗司可预防铁调素敲除小鼠全身铁过载诱导的视网膜变性。
Invest Ophthalmol Vis Sci. 2014 Jun 26;55(7):4525-32. doi: 10.1167/iovs.14-14568.
4
Mechanism Underlying the Effectiveness of Deferiprone in Alleviating Parkinson's Disease Symptoms.地拉罗司在缓解帕金森病症状方面的有效性的作用机制。
ACS Chem Neurosci. 2018 May 16;9(5):1118-1127. doi: 10.1021/acschemneuro.7b00478. Epub 2018 Feb 27.
5
Attenuating effect of paroxetine on memory impairment following cerebral ischemia-reperfusion injury in rat: The involvement of BDNF and antioxidant capacity.帕罗西汀对脑缺血再灌注损伤后大鼠记忆障碍的衰减作用:BDNF 和抗氧化能力的参与。
Eur J Pharmacol. 2021 Feb 15;893:173821. doi: 10.1016/j.ejphar.2020.173821. Epub 2020 Dec 18.
6
Deferiprone ameliorates memory impairment in Scopolamine-treated rats: The impact of its iron-chelating effect on β-amyloid disposition.地拉罗司改善东莨菪碱处理大鼠的记忆障碍:其螯合铁效应对β-淀粉样蛋白分布的影响。
Behav Brain Res. 2020 Jan 27;378:112314. doi: 10.1016/j.bbr.2019.112314. Epub 2019 Oct 20.
7
A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.铁螯合剂与抗氧化剂联合应用比单一药物治疗对铁过载地中海贫血小鼠的心脏保护作用更大。
Free Radic Res. 2018 Jan;52(1):70-79. doi: 10.1080/10715762.2017.1414208. Epub 2017 Dec 19.
8
From small deferiprone to macromolecular micelles: Self-assembly enhances iron chelation.从小的去铁酮到大分子胶束:自组装增强铁螯合。
J Colloid Interface Sci. 2019 Jan 1;533:375-384. doi: 10.1016/j.jcis.2018.08.086. Epub 2018 Aug 25.
9
The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.口服铁螯合剂地拉罗司可预防铁过载诱导的视网膜变性。
Invest Ophthalmol Vis Sci. 2011 Feb 16;52(2):959-68. doi: 10.1167/iovs.10-6207.
10
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.铁螯合剂地拉罗司改善tau 病模型小鼠的表型。
J Alzheimers Dis. 2020;77(2):753-771. doi: 10.3233/JAD-200551.

引用本文的文献

1
Ferroptosis as a potential molecular mechanism of bipolar disorder.铁死亡作为双相情感障碍的一种潜在分子机制。
Transl Psychiatry. 2025 Jun 19;15(1):205. doi: 10.1038/s41398-025-03429-w.
2
Mitochondrial ferritin upregulation by deferiprone reduced neuronal ferroptosis and improved neurological deficits via NDRG1/Yap pathway in a neonatal rat model of germinal matrix hemorrhage.在生发基质出血新生大鼠模型中,去铁酮上调线粒体铁蛋白通过NDRG1/Yap途径减少神经元铁死亡并改善神经功能缺损。
J Cereb Blood Flow Metab. 2025 Mar;45(3):510-527. doi: 10.1177/0271678X241252110. Epub 2024 Sep 24.
3
Deferiprone promoted remyelination and functional recovery through enhancement of oligodendrogenesis in experimental demyelination animal model.
去铁酮通过增强实验性脱髓鞘动物模型中的少突胶质细胞生成来促进髓鞘再生和功能恢复。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):715-727. doi: 10.1007/s00210-024-03314-1. Epub 2024 Jul 24.
4
A high fat diet potentiates neonatal iron overload-induced memory impairments in rats.高脂饮食会增强新生大鼠铁过载诱导的记忆损伤。
Eur J Nutr. 2024 Jun;63(4):1163-1175. doi: 10.1007/s00394-024-03333-x. Epub 2024 Feb 15.
5
Impact of NQO1 dysregulation in CNS disorders.NQO1 失调对中枢神经系统疾病的影响。
J Transl Med. 2024 Jan 2;22(1):4. doi: 10.1186/s12967-023-04802-3.
6
Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression.Nrf2 调控抑郁中海马突触和功能连接损伤中铁依赖性作用。
J Neuroinflammation. 2023 Sep 21;20(1):212. doi: 10.1186/s12974-023-02875-x.
7
Neurodegenerative Diseases: Implications of Environmental and Climatic Influences on Neurotransmitters and Neuronal Hormones Activities.神经退行性疾病:环境和气候因素对神经递质和神经元激素活性的影响。
Int J Environ Res Public Health. 2022 Sep 30;19(19):12495. doi: 10.3390/ijerph191912495.
8
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression.新型抗抑郁药铁螯合剂地拉罗司在抑郁小鼠模型中的作用。
Neurotherapeutics. 2022 Sep;19(5):1662-1685. doi: 10.1007/s13311-022-01257-0. Epub 2022 Jul 21.
9
Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.地拉罗司治疗老年转基因 Tau 小鼠可改善 Y 迷宫表现并改变 Tau 病理学。
Neurotherapeutics. 2021 Apr;18(2):1081-1094. doi: 10.1007/s13311-020-00972-w. Epub 2021 Jan 6.
10
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach.小胶质细胞激活的药理学靶向:新的治疗方法。
Front Cell Neurosci. 2019 Nov 19;13:514. doi: 10.3389/fncel.2019.00514. eCollection 2019.